317-622-8970 Back to results

Pharmacentrix Ltd

New York City, New York

New York City, New York, United States7 employees$1.6M revenue
Visit Website

Find prospects like Pharmacentrix Ltd

Get a list of similar companies, matched by industry, size and location, ready for outreach.

Free sample of 25 companies by email within one business day. No spam: we only use your email for this request.

About Pharmacentrix Ltd

Pharmacentrix primary objective is to market a comprehensive range of high quality chemotherapy and cancer-related diagnostic and genomic testing products.

Its primary NAICS classification is 325412 (Pharmaceutical Preparation Manufacturing). Pharmacentrix Ltd is one of 5,245,681 companies listed in New York.

Business Contact Information

Address
123 Main St, New York City, New York, 10001, United States

Industry & Classification

NAICS Codes

  • 32
  • 3254Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing

SIC Codes

  • 28Chemicals And Allied Products
  • 283Drugs
  • 2834Pharmaceutical Preparation Mfg.

Company Details

Employees
7 (6-10)
Annual Revenue
$1.6M ($1M-$5M)

Pharmacentrix Ltd: frequently asked questions

What does Pharmacentrix Ltd do?

Pharmacentrix primary objective is to market a comprehensive range of high quality chemotherapy and cancer-related diagnostic and genomic testing products.

Where is Pharmacentrix Ltd located?

Pharmacentrix Ltd is headquartered at 123 Main St, New York City, New York, 10001, United States.

How many employees does Pharmacentrix Ltd have?

Pharmacentrix Ltd has about 7 employees (the 6-10 range).

What is Pharmacentrix Ltd's annual revenue?

Pharmacentrix Ltd's annual revenue is estimated at $1.6M (the $1M-$5M range).

What industry is Pharmacentrix Ltd in?

Pharmacentrix Ltd's primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

How can I contact Pharmacentrix Ltd?

Its website is pharmacentrix.co.za.

Largest companies in New York

Largest companies on Factur

Manufacturing sales in New York, 2026

In New York, Factur's 2026 study counted 53 manufacturing quotes worth $5M and 8 purchase orders over 12 months: 15% of quotes became orders, against 21% nationally. See the New York data.

Own this business?

Keep your profile accurate — or ask us to take it down. We acknowledge requests within 7 days and resolve them within 30 days.

Prefer email? privacy@facturmfg.com

Add this badge to your website — show visitors you're listed on Factur Data.